TMSIX
Price
$37.49
Change
-$0.20 (-0.53%)
Updated
Sep 20 closing price
VIMSX
Price
$71.38
Change
-$0.13 (-0.18%)
Updated
Sep 20 closing price
Ad is loading...

TMSIX vs VIMSX

Header iconTMSIX vs VIMSX Comparison
Open Charts TMSIX vs VIMSXBanner chart's image
Thrivent Mid Cap Stock S
Price$37.49
Change-$0.20 (-0.53%)
VolumeN/A
CapitalizationN/A
Vanguard Mid Cap Index Investor
Price$71.38
Change-$0.13 (-0.18%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
TMSIX vs VIMSX Comparison Chart
Loading...
VS
TMSIX vs. VIMSX commentary
Sep 21, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is TMSIX is a StrongBuy and VIMSX is a Buy.

FUNDAMENTALS
Fundamentals
VIMSX has more cash in the bank: 172B vs. TMSIX (4.11B). VIMSX pays higher dividends than TMSIX: VIMSX (1.38) vs TMSIX (0.39). TMSIX was incepted earlier than VIMSX: TMSIX (27 years) vs VIMSX (26 years). TMSIX is a more actively managed with annual turnover of: 32.00 vs. VIMSX (13.00). TMSIX has a lower initial minimum investment than VIMSX: TMSIX (2000) vs VIMSX (3000). VIMSX annual gain was more profitable for investors over the last year : 25.11 vs. TMSIX (18.41). VIMSX return over 5 years is better than : 56.75 vs. TMSIX (39.82).
TMSIXVIMSXTMSIX / VIMSX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence27 years26 years-
Gain YTD9.65212.55777%
Front LoadN/AN/A-
Min. Initial Investment2000300067%
Min. Initial Investment IRAN/AN/A-
Net Assets4.11B172B2%
Annual Yield % from dividends0.391.3828%
Returns for 1 year18.4125.1173%
Returns for 3 years-3.029.82-31%
Returns for 5 years39.8256.7570%
Returns for 10 years53.96128.2142%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
INSE10.090.15
+1.51%
Inspired Entertainment
FOUR86.901.01
+1.18%
Shift4 Payments
CALT40.00-0.16
-0.40%
Calliditas Therapeutics AB
BCE35.04-0.15
-0.43%
BCE
ACST2.70-0.08
-2.88%
Acasti Pharma